CLINICAL_TRIALS
trial_result
· 2013-01-14
Clinical Trial Update: Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer [Phase 3]
Summary
Phase 3 trial comparing sunitinib malate to sorafenib in inoperable hepatocellular carcinoma was terminated with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: TERMINATED | Results posted: 2013-01-14